• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPECTRANETICS STELLAREX 0.014 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPECTRANETICS STELLAREX 0.014 OTW DRUG-COATED ANGIOPLASTY BALLOON; DCB PTA CATHETER Back to Search Results
Model Number A14SX030150150T
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Swelling (2091)
Event Date 04/03/2019
Event Type  Injury  
Manufacturer Narrative
The patient experienced swelling and pain at the puncture site.This is being reported as part of a clinical study.Report source: foreign- (b)(6).Pma number is not applicable.The device is ce marked that was used as part of a clinical study under an ide.During the index procedure, the product worked as intended, thus no returned product evaluation was required.Per the ifu, pain at the insertion site is listed as a potential complications/adverse events.
 
Event Description
It was reported through a clinical study that during the index procedure on (b)(6) 2019, a stellarex catheter was used to treat the target lesion of the left distal popliteal artery.Seven days post index procedure, the patient was in the outpatient clinic due to swelling and pain in the right groin from the procedure.The physician excluded pseudoaneurysm and re-bleeding, thus recommended protection of the puncture site and for patient to return in case the condition of the puncture site deteriorates.The physician indicated this was related to the procedure and unlikely related to the study device.
 
Manufacturer Narrative
Block g5: pma number is not applicable.Upon further review, it was identified that this complaint was not required to be reported through this process.This is a non-commercial product that is captured under the ide for the illuminate btk clinical study.H3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLAREX 0.014 OTW DRUG-COATED ANGIOPLASTY BALLOON
Type of Device
DCB PTA CATHETER
Manufacturer (Section D)
SPECTRANETICS
6531 dumbarton circle
fremont CA 94555
MDR Report Key8574297
MDR Text Key143853467
Report Number3009784280-2019-00154
Device Sequence Number1
Product Code ONU
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,study
Type of Report Initial,Followup
Report Date 01/01/2005,04/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/27/2018
Device Model NumberA14SX030150150T
Device Catalogue NumberA14SX030150150T
Device Lot NumberCRX17K11A
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 04/10/2019
Initial Date FDA Received05/02/2019
Supplement Dates Manufacturer Received07/11/2019
Supplement Dates FDA Received07/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
UNK MFG AND SIZE: GUIDE CATHETER; UNK MFG AND SIZE: GUIDE WIRE; UNK MFG AND SIZE: INTRODUCER SHEATH; UNK MFG AND SIZE: GUIDE CATHETER; UNK MFG AND SIZE: GUIDE WIRE; UNK MFG AND SIZE: INTRODUCER SHEATH
Patient Outcome(s) Hospitalization;
Patient Age60 YR
Patient Weight100
-
-